Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-03-30
DOI
10.3389/fphar.2017.00162
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical relevance of the bile acid receptor TGR5 in metabolism
- (2017) F Samuel van Nierop et al. Lancet Diabetes & Endocrinology
- Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?
- (2016) R. J. Hodge et al. DIABETES OBESITY & METABOLISM
- Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders
- (2016) Roberto Pellicciari et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules
- (2016) Bryan L. Copple et al. PHARMACOLOGICAL RESEARCH
- Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists
- (2016) Valentina Sepe et al. Scientific Reports
- Navigation in bile acid chemical space: discovery of novel FXR and GPBAR1 ligands
- (2016) Claudia Finamore et al. Scientific Reports
- Receptor-based virtual screening protocol for drug discovery
- (2015) Nuno M.F.S.A. Cerqueira et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Bile Acids as Hormones: The FXR-FGF15/19 Pathway
- (2015) Steven A. Kliewer et al. DIGESTIVE DISEASES
- Farnesoid X receptor modulators (2011 – 2014): a patent review
- (2015) Valentina Sepe et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical application
- (2015) Valentina Sepe et al. Future Medicinal Chemistry
- OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
- (2015) Edward Harder et al. Journal of Chemical Theory and Computation
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders
- (2015) Stefano Fiorucci et al. TRENDS IN MOLECULAR MEDICINE
- Structure-based drug design targeting the cell membrane receptor GPBAR1: exploiting the bile acid scaffold towards selective agonism
- (2015) Francesco Saverio Di Leva et al. Scientific Reports
- The Bile Acid Receptor TGR5 Activates the TRPA1 Channel to Induce Itch in Mice
- (2014) TinaMarie Lieu et al. GASTROENTEROLOGY
- A liquid chromatography-tandem mass spectrometry-based method for the simultaneous determination of hydroxy sterols and bile acids
- (2014) Clara John et al. JOURNAL OF CHROMATOGRAPHY A
- Design, Synthesis, and Biological Evaluation of Potent Dual Agonists of Nuclear and Membrane Bile Acid Receptors
- (2014) Claudio D’Amore et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploitation of Cholane Scaffold for the Discovery of Potent and Selective Farnesoid X Receptor (FXR) and G-Protein Coupled Bile Acid Receptor 1 (GP-BAR1) Ligands
- (2014) Carmen Festa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dissociation of Intestinal and Hepatic Activities of FXR and LXR Supports Metabolic Effects of Terminal Ileum Interposition in Rodents
- (2013) A. Mencarelli et al. DIABETES
- The TGR5 receptor mediates bile acid–induced itch and analgesia
- (2013) Farzad Alemi et al. JOURNAL OF CLINICAL INVESTIGATION
- Binding Mechanism of the Farnesoid X Receptor Marine Antagonist Suvanine Reveals a Strategy To Forestall Drug Modulation on Nuclear Receptors. Design, Synthesis, and Biological Evaluation of Novel Ligands
- (2013) Francesco Saverio Di Leva et al. JOURNAL OF MEDICINAL CHEMISTRY
- Counter-Regulatory Role of Bile Acid Activated Receptors in Immunity and Inflammation
- (2012) S. Fiorucci et al. CURRENT MOLECULAR MEDICINE
- Editorial [Hot Topic :Current Advances In Therapeutic Applications of Nuclear Receptors (Guest Editor: Stefano Fiorucci)]
- (2012) Stefano Fiorucci CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Development of FXR, PXR and CAR Agonists and Antagonists for Treatment of Liver Disorders
- (2012) Stefano Fiorucci et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Farnesoid X receptor: from medicinal chemistry to clinical applications
- (2012) Stefano Fiorucci et al. Future Medicinal Chemistry
- Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice
- (2011) Stefano Fiorucci et al. BRITISH JOURNAL OF PHARMACOLOGY
- New Insight into the Central Benzodiazepine Receptor–Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds
- (2011) Maurizio Anzini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Farnesoid X Receptor Agonist for the Treatment of Liver and Metabolic Disorders: Focus on 6-ethyl-CDCA
- (2011) S. Fiorucci et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling
- (2011) Tingting Li et al. MOLECULAR ENDOCRINOLOGY
- Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution
- (2010) Jeremy R. Greenwood et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- 2 FARNESOID-X RECEPTOR AGONISTS: A NEW CLASS OF DRUGS FOR THE TREATMENT OF PBC? AN INTERNATIONAL STUDY EVALUATING THE ADDITION OF INT-747 TO URSODEOXYCHOLIC ACID
- (2010) A. Mason et al. JOURNAL OF HEPATOLOGY
- Breaking the Dogma of the Metal-Coordinating Carboxylate Group in Integrin Ligands: Introducing Hydroxamic Acids to the MIDAS To Tune Potency and Selectivity
- (2009) Dominik Heckmann et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeting Farnesoid-X-Receptor: From Medicinal Chemistry to Disease Treatment
- (2009) S. Fiorucci et al. CURRENT MEDICINAL CHEMISTRY
- Farnesoid X receptor agonists in biliary tract disease
- (2009) Stefano Fiorucci et al. CURRENT OPINION IN GASTROENTEROLOGY
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Bile acid-activated receptors in the treatment of dyslipidemia and related disorders
- (2009) Stefano Fiorucci et al. PROGRESS IN LIPID RESEARCH
- Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders
- (2009) Stefano Fiorucci et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Ethyl 8-Fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as Novel, Highly Potent, and Safe Antianxiety Agent
- (2008) Maurizio Anzini et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation